Eficacia inhibitoria de ciprofloxacina ótica y doxiciclina sobre cepas de Prevotella intermedia: Estudio in vitro
DOI:
https://doi.org/10.29166/odontologia.vol19.n2.5-16Keywords:
Periodontics, periodontitis, drug TherapyAbstract
Ciprofloxacin has been proposed as an alternative for local application in complementary therapy of periodontal treatment. Its topical (otic) form presents as a low cost and effective alternative against periodontopathogens. Objective: To determine the inhibitory effect of Ciprofloxacin otica (CIP) and Doxycycline (DOXI) on strains of Prevotella intermedia (Pi). Materials and methods: Experimental study, in vitro. The sample was consisted of cultures of Pi ATCC®25611 in Agar Mueller Hinton to determine by the antibiotic susceptibility test the inhibition halo. CIP-5ug / 10ul discs (G1 n = 10) were placed; DOXI-5ug discs (G2 n = 10); and, physiological saline discs-10ul (G3 n = 10). After 24 hours of incubation, halos were measured using Antibiotic Zone Scale (mm) with the parameters of the BD BBL Sensi-Disc Antimicrobial Suceptibibility Test Disc., With the following parameters: DOXI: resistant <12 mm, intermediate 13-15 mm, sensitive> 16 mm; CIPO: resistant <15 mm, intermediate 16-20 mm, sensitive> 21 mm. The Mann Whitney U test was used with a level of significance of 5%. Results: All the inhibition zones of both groups presented values higher tan the sensitivity parameters (100% effectiveness). Median for doxycycline was 38 mm and ciprofloxacin was 36 mm. There was a statistically significant difference for the G1 and G2 groups when compared with the reference values (p <0.05). Conclusion: Local ciprofloxacin demonstrated the same efficacy as doxycycline on strains of Prevotella intermedia.
Downloads
References
Xiong X, Buekens P, Fraser W, Beck J, Offenbacher S. Periodontal disease and adverse pregnancy outcomes: a systematic review. BJOG: An International Journal of Obstetrics and Gynaecology. 2006; 113(2): 135–43.
Holt SC, Ebersole JL. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the ‘red complex’, a prototype polybacterial pathogenic consortium in periodontitis. Periodontology 2000. 2005; 38(1): 72–122.
Socransky SS, Haffajee AD, Smith C, Martin L, Haffajee JA, Uzel NG, et al. Use of checkerboard DNA–DNA hybridization to study complex microbial ecosystems. Molecular Oral Microbiology. 2004; 19(6): 352–62.
Torrungruang K, Jitpakdeebordin S, Charatkulangkun O, Gleebbua Y. Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, and Treponema denticola / Prevotella intermedia Co-Infection Are Associated with Severe Periodontitis in a Thai Population. PLoS One. 2015; 10 (8): e0136646.
Gatto MR, Montevecchi M, Paolucci M, Landini MP, Checchi L. Prevalence of six periodontal pathogens in subgingival samples of Italian patients with chronic periodontitis. New Microbiol. 2014; 37(4): 517–24.
Teles RP, Haffajee AD, Socransky SS. Microbiological goals of periodontal therapy. Periodontology 2000. 2006; 42(1):180–218.
Ishikawa I, Baehni P. Tratamiento periodontal no quirúrgico ¿ Dónde nos encontramos ? Periodontology 2000. 2005; 11(1): 9-13.
Aoki A, Miyuki K, Watanabe H, Ishikawa I. Láser en el tratatamiento periodontal no quirúrgico. Periodontolgy 2000. 2005; 11(1):59-97.
Jepsen K, Jepsen S. Antibiotics/antimicrobials: systemic and local administration in the therapy of mild to moderately advanced periodontitis. Periodontology 2000. 2016; 71(1): 82–112.
Slots J, Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontology 2000. 2002; 28(1): 106–76.
Matesanz-Pérez P, García-Gargallo M, Figuero E, Bascones-Martínez A, Sanz M, Herrera D. A systematic review on the effects of local antimicrobials as adjuncts to subgingival debridement, compared with subgingival debridement alone, in the treatment of chronic periodontitis. Journal of Clinical Periodontology. 2013; 40(3): 227–41.
Chambrone L, Vargas M, Arboleda S, Serna M, Guerrero M, de Sousa J, et al. Efficacy of Local and Systemic Antimicrobials in the Non-Surgical Treatment of Smokers with Chronic Periodontitis: A Systematic Review. Journal of Periodontology. 2016; 87(11):1320–32.
Hanes P, Purvis J. Local anti-efective theraphy: Pharmacological Agents. A systematic review. Annals of Periodontology. 2003; 8(1): 79-98.
Da Rocha HA, Silva CF, Santiago FL, Martins LG, Dias PC, De Magalhães D. Local drug delivery systems in the treatment of periodontitis: A literature review. J Int Acad Periodontol. 2015; 17(3): 82–90.
Prakasam A, Elavarasu S, Natarajan R. Antibiotics in the management of aggressive periodontitis. J Pharma Bioallied Sci. 2012; 4(2): S252-5.
Pathak K, Sharma V, Singh K, Chhabra G. Thermosensitive periodontal sol of ciprofloxacin hydrochloride and serratiopeptidase: Pharmaceutical and mechanical analysis. International Journal of Pharmaceutical Investigation. 2014; 4(1): 5-14.
Alamanda M, Denthumdas SK, Wadgave U, Pharne PM, Patil SJ, Kondreddi S, Deshpande P, Koppikar RS.Comparative Evaluation of Ciprofloxacin Levels in GCF and Plasma of Chronic Periodontitis Patients: Quasi Experimental Study. Global Journal of Health Science. 2014; 6(7): 48-50
Samarei R. Comparison of local and systemic ciprofloxacin ototoxicity in the treatment of chronic media otitis. Glob J Health Sci. 2014; 6(7): 144-9.
Japoni A, Vasin A, Noushadi S, Kiany F, Japoni S, Alborzi A. Antibacterial susceptibility patterns of Porphyromonas gingivalis isolated from chronic periodontitis patients. Med Oral Patol Oral Cir Bucal. 2011; 16(7): e1031-5.
Rams TE, Feik D, Mortensen JE, Degener JE, van Winkelhoff AJ. Antibiotic susceptibility of periodontal Streptococcus intermedius clinical isolates. J Periodontol. 2014; 85(12): 1792-8.
Heasman PA, Vernazza CR, Gaunt FL, Pennington MW. Cost-effectiveness of adjunctive antimicrobials in the treatment of periodontitis. Periodontology 2000. 2011; 55(1): 217-30.
Barça E, Çifçibasi E, Çintan S. Adjunctive use of antibiotics in periodontal therapy. Istanbul Üniversitesi Dis Hekimligi Fakültesi Dergisi. 2015; 49(3):55.
Bidault P, Chandad F, Grenier D. Risk of Bacterial Resistance Associated with Systemic Antibiotic Therapy in Periodontology. J Can Dent Assoc. 2007; 73(8): 721-5.
Palacio A, Herrera L, Duque A. Sistemas de liberación controlada de antimicrobianos. CES Odont. 2008; 21(2): 69-77.
Gillam DG, Turner W. Antibiotics in the treatment of periodontal disease: a guide for the general dental practitioner. Prim Dent J. 2014 Aug; 3(3):43-7
Rovai E, Souto M, Ganhito J, Holzhausen M, Chambrone, l, Pannuti C. Efficacy of Local Antimicrobials in the Nonsurgical Treatment of Periodontitis Patients With Diabetes: A Systematic Review. Journal of Periodontology. 2016; 87(12): 1406-17.
Belibasakis GN, Thurnheer T. Validation of Antibiotic Efficacy on In Vitro Subgingival Biofilms. J Periodontol. 2014; 85(2): 343-8.
Zandbergen D, Slot DE, Niederman R, Van der Weijden FA. The concomitant administration of systemic amoxicillin and metronidazole compared to scaling and root planing alone in treating periodontitis: =a systematic review=. BMC Oral Health. 2016 Feb 29; 16:27.
Jaramillo AE, Betancourth MQ, Mayorga-Fayad I, Castillo DMP, Aya MRC, Lafaurie GIV, Botero JET, Contreras AR. Perfiles antimicrobianos de bacterias subgingivales en pacientes con periodontitis en Colombia. Revista Clínica de Periodoncia, Implantología y Rehabilitación Oral. 2008;1(2): 61–5.
Froum SJ, Weinberg MA. An Evaluation of Antibiotic Use in Periodontal and Implant Practices. Int J Periodontics Restorative Dent. 2015;35(4): 481-7.
